The US government is clashing with Anthropic over AI safety regulation. This could signal a shift from voluntary to mandatory regulation.
The US government is in a regulatory dispute with AI company Anthropic. The article uses a drug regulation analogy to describe how the government, dissatisfied with voluntary safety measures, eventually banned the product.
The US has historically taken a laissez-faire approach to AI regulation. However, after Anthropic refused the government's voluntary program, the government shifted to a hardline stance.
This incident signals a new era in AI governance, potentially moving from voluntary to mandatory regulation, which could have major implications for the entire industry.
The comment criticizes the use of metaphors, arguing that comparing LLMs to drugs or government regulation to the FDA is invalid, especially given that LLMs can be trivially copied as files. It questions the effectiveness of regulation, reflecting a skeptical view on AI governance.